Skip to main content
. 2017 Oct 31;12(10):e0186821. doi: 10.1371/journal.pone.0186821

Fig 4. MTT viability assay of EEDQ LPs.

Fig 4

Viability of Hela cells (A), HepG cells (B) and HEK-293T cells (C)after treatment with EEDQ2, LP-EEDQ2 or Tf-LP-EEDQ2 at the concentration of 0–30 mg/ ml for 24 h. The cells treated with PBS were used as control. (*p<0.05, **p<0.01: LP-EEDQ2 VS Tf-LP-EEDQ2).